Literature DB >> 11923379

One-point population analysis and effect of osmolarity on detection of hetero-vancomycin-resistant Staphylococcus aureus.

Sook-In Jung1, Sungmin Kiem, Nam Yong Lee, Yeon-Sook Kim, Won Sup Oh, Hwang Lae Cho, Kyong Ran Peck, Jae-Hoon Song.   

Abstract

The original screening test and one-point population analysis (OPPA) were compared for the detection of hetero-vancomycin-resistant Staphylococcus aureus, and the influence of osmolarity on those tests was evaluated. The positivity rates and the reproducibilities were similar for both tests. The addition of NaCl increased the MIC as well as the positivity rates for both tests and the reproducibility of OPPA.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11923379      PMCID： PMC140347          DOI： 10.1128/JCM.40.4.1493-1495.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  6 in total

1.  Heterogeneous resistance to vancomycin in Staphylococcus aureus.

Authors:  R A Howe; M Wootton; T R Walsh; P M Bennett; A P Macgowan
Journal:  J Antimicrob Chemother       Date:  2000-01       Impact factor: 5.790

2.  Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.

Authors:  K Hiramatsu; N Aritaka; H Hanaki; S Kawasaki; Y Hosoda; S Hori; Y Fukuchi; I Kobayashi
Journal:  Lancet       Date:  1997-12-06       Impact factor: 79.321

3.  Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

Authors:  K Hiramatsu; H Hanaki; T Ino; K Yabuta; T Oguri; F C Tenover
Journal:  J Antimicrob Chemother       Date:  1997-07       Impact factor: 5.790

4.  Salt-supplemented medium for testing methicillin-resistant staphylococci with newer beta-lactams.

Authors:  J H Jorgensen; J S Redding; L A Maher; P E Ramirez
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

5.  A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital.

Authors:  M Wootton; R A Howe; R Hillman; T R Walsh; P M Bennett; A P MacGowan
Journal:  J Antimicrob Chemother       Date:  2001-04       Impact factor: 5.790

6.  Glycopeptide-intermediate Staphylococcus aureus: evaluation of a novel screening method and results of a survey of selected U.S. hospitals.

Authors:  S K Hubert; J M Mohammed; S K Fridkin; R P Gaynes; J E McGowan; F C Tenover
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948
  6 in total
  4 in total

1.  Laboratory detection and investigation of reduced susceptibility to vancomycin in oxacillin-resistant Staphylococcus aureus.

Authors:  P D Midolo; T M Korman; D Kotsanas; P Russo; T G Kerr
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-05       Impact factor: 3.267

Review 2.  Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications.

Authors:  Benjamin P Howden; John K Davies; Paul D R Johnson; Timothy P Stinear; M Lindsay Grayson
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

3.  Nationwide surveillance for Staphylococcus aureus with reduced susceptibility to vancomycin in Korea.

Authors:  Hong Bin Kim; Wan Beom Park; Ki Deok Lee; Young Joo Choi; Sang Won Park; Myoung-Don Oh; Eui-Chong Kim; Kang Won Choe
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

4.  The Role of β-Glycosylated Wall Teichoic Acids in the Reduction of Vancomycin Susceptibility in Vancomycin-Intermediate Staphylococcus aureus.

Authors:  Michael Hort; Ute Bertsche; Senada Nozinovic; Alina Dietrich; Anne Sophie Schrötter; Laura Mildenberger; Katharina Axtmann; Anne Berscheid; Gabriele Bierbaum
Journal:  Microbiol Spectr       Date:  2021-10-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.